News for Anixa Biosciences Inc Stock (ANIX)

Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology

PRNewsWire • 08/18/21

ANIX Stock Price: Over 15% Increase Pre-Market Explanation

Pulse2 • 05/27/21

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic

PRNewsWire • 05/26/21

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

PRNewsWire • 05/20/21

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

PRNewsWire • 05/07/21

Anixa's Stock Craters As FDA Slaps Clinical Hold On CAR-T Program

Benzinga • 04/19/21

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy

PRNewsWire • 04/19/21

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

PRNewsWire • 04/05/21

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

PRNewsWire • 03/23/21

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

PRNewsWire • 03/22/21

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy

PRNewsWire • 03/22/21

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

PRNewsWire • 03/12/21

Anixa Biosciences (ANIX) Catches Eye: Stock Jumps 8.7%

Zacks Investment Research • 12/11/20

Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office

PRNewsWire • 07/10/20

Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds

PRNewsWire • 07/06/20

Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline

PRNewsWire • 07/02/20